ABOUT THE CONFERENCE
Genetic testing utilization management has become a major concern for Health Plans as direct-to-consumer promotions of new genetic tests and panels increase through a constant barrage of news articles and marketing campaigns to both physicians and the general public. Unmanaged genetic testing can create unnecessary, negative downstream medical issues, risks, and increased costs. Deciding which genetic tests provide clinical validity, utility and effectiveness is the first step and proper utilization management is the next step.
At this conference, Health Plans will hear the latest ideas on where they should focus their efforts for genetic testing in the future, as well as the latest news on CMS genetic testing reimbursement and recommendations from national medical and genetic organizations on cancer genetic testing.
This conference is designed exclusively for Health Plan and ACO Medical Directors, Network Management Executives, Medical Policy and Reimbursement/Contracting personnel, in addition to anyone involved in utilization management and contracting of genetic and laboratory tests.
KENTMERE HEALTHCARE CONSULTING CORPORATION
Since 2000, Kentmere Healthcare Consulting Corporation provides its proprietary outpatient Kentmere Laboratory Benefit Management Program™ for the managed care industry, which manages Health Plan utilization, cost, and mix of outpatient clinical, pathology, and genomic laboratory testing. Kentmere exclusively serves national and regional health plans, is not a laboratory, and does not work for or with laboratory providers.
AGENDA & SPEAKER BIOS
View the Agenda & Speaker Bios PDF
MODERATOR & SPEAKER
Russel Kaufman, MD, FACP, FCCP, Chief Medical Officer, Kentmere Healthcare Consulting Corporation; Hematologist/Oncologist and Cancer Geneticist; former Dean and Vice-Chancellor, Duke University Medical School; former CEO, The Wistar Institute
SPEAKERS
Mike Barlow, Vice President, Palmetto GBA, Centers for Medicare & Medicaid Services Medicare Administrative Contractors
Elaine Jeter, MD, MolDx Medical Director, Palmetto GBA, Centers for Medicare & Medicaid Services Medicare Administrative Contractors
Edith Mitchell, MD, FACP, Program Leader, Gastrointestinal Oncology at Sidney Kimmel Medical College at Thomas Jefferson University; President, National Medical Association
Donald L. (Skip) Trump, MD, FACP, CEO Executive Director, Inova Schar Cancer Institute; former President and CEO, Roswell Park Cancer Institute
and Additional Speakers
TOPICS
- Genetic Testing: Determining Value Amidst a Sea of Marketing to Physicians, Patients and Plans. What is the Cost of the $999 Human Genome Sequence?
- A Point-Counterpoint Discussion On NGS Testing, Coverage and Reimbursement
- The Power of NGS: Non-Invasive Prenatal Testing and Liquid Biopsies
- How Research Drives The Evolution of Prostate Cancer Screening and Molecular Profiling
- Pharmacogenomics and the Basis of Targeted, Personalized Therapies: The Right Drug at the Right Time to the Right Person
- Colorectal Cancer: Genetic Testing for Screening, Susceptibility, Prognosis, and Targeted Therapies – What is a Clinician to Do!
- PAMA and NGS Technology in Pricing Genetic Tests
- Navigating the Minefield of Genetic Testing UM; Operational, Financial and Medical
REGISTRATION*/TICKETS
Still some seats available! Registration extended to June 21. Tickets will not be sold at the door.
*This event is for Health Plans and ACOs ONLY. Kentmere has the right to deny admission and refund ticket purchases made by or for any organization and/or person that is not a health plan or ACO or an employee of a health plan or ACO.
No Refunds after June 21, 2016.
Don't want to register online? Call us at 302-478-7600
